Kontorinis Nickolas, Agarwal Kaushik, Elhajj Nassim, Fiel M Isabel, Schiano Thomas D
Division of Liver Diseases, Recanati-Miller Transplantation Institute, New York, NY 10029, USA.
Liver Transpl. 2006 May;12(5):827-30. doi: 10.1002/lt.20706.
A 55-year-old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune-mediated hepatitis.
一名55岁的白种男性在完成聚乙二醇干扰素和利巴韦林治疗复发性丙型肝炎后,患上了一种特征明确的自身免疫性肝炎。我们推测聚乙二醇干扰素引发了一种严重的免疫介导性肝炎。